Oct 4, 2022
Odyssey Health (OTC: ODYY), an enterprise committed to developing unique, life-enhancing medical products, marked a successful close of the second Cohort of its Phase I Multi-Day Ascending Dosing (“MAD”) clinical trial (https://ibn.fm/pnUwS).
While making the announcement, Odyssey’s Chief Executive Officer (“CEO”), Michael Redmond, expressed how pleased he was with the safety profile of the company’s…
NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.
The BBC's Samira Hussain breaks down the AI company's first day as a publicly traded company, as shares closed up 17%.
Anthropic is the first purely AI company to be publicly listed, creating a test for the entire industry.
The gamers staying home in droves have to be fed, and the meal business is more than ready to feed them.
The probe by California, where the AI chipmaker has its global headquarters, follows former CEO Jensen Huang's departure.
See how much of the stock you may own through common index funds, like those found in retirement accounts.
The website has been checked and cited often during an unusually busy week of technology problems, though its operators acknowledge its limitations.
The bank, which earlier this week suffered a brief technology outage, said no sensitive information was taken in an incident that also affected Mastercard and Visa.
Placing a meaningful portion of your wealth on a single stock is never a good idea, but if you feel tempted to invest, ask yourself several questions first.
An early investment that Facebook co-founder Dustin Moskovitz made in Anthropic is paying off. But it’s not making him happy.
Anthropic excluded investment firms from China and Hong Kong from buying shares in advance of its initial public offering.
Walmart and Target are among the retailers that say shoppers are trying to save money amid broader concerns about the U.S. economy. And sales are up.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.